Novavax Aktie
WKN DE: A2PKMZ / ISIN: US6700024010
| 09.11.2023 14:03:49 | 
Novavax Inc. Q3 Loss decreases, beats estimates
(RTTNews) - Novavax Inc. (NVAX) revealed Loss for third quarter that decreased from the same period last year and missed the Street estimates.
The company's bottom line came in at -$130.78 million, or -$1.26 per share. This compares with -$168.61 million, or -$2.15 per share, in last year's third quarter.
Analysts on average had expected the company to earn -$1.67 per share, according to figures compiled by Thomson Reuters. Analysts' estimates typically exclude special items.
The company's revenue for the quarter fell 74.5% to $186.99 million from $734.58 million last year.
Novavax Inc. earnings at a glance (GAAP) :
-Earnings (Q3): -$130.78 Mln. vs. -$168.61 Mln. last year. -EPS (Q3): -$1.26 vs. -$2.15 last year. -Analyst Estimates: -$1.67 -Revenue (Q3): $186.99 Mln vs. $734.58 Mln last year.
-Guidance: Full year revenue guidance: $900 - $1100 Mln
 Der finanzen.at Ratgeber für Aktien!
						
						
						
							
								Der finanzen.at Ratgeber für Aktien!
							
							Wenn Sie mehr über das Thema Aktien erfahren wollen, finden Sie in unserem Ratgeber viele interessante Artikel dazu!
Jetzt informieren!
Nachrichten zu Novavax Inc.mehr Nachrichten
| 05.08.25 | Ausblick: Novavax zieht Bilanz zum jüngsten Jahresviertel (finanzen.net) | 
Analysen zu Novavax Inc.mehr Analysen
Aktien in diesem Artikel
| Novavax Inc. | 7,31 | -0,10% |  | 
 
									 
									 
								